Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
NITAG documentation
Adults
Newborn
Clear all
Type of publications
NITAG documentation
(16)
SAGE documentation
(3)
Systematic reviews (SYSVAC)
(1141)
Topics
Agenda & Minutes
(2)
Recommendation
(14)
Regions
Africa
(1)
Americas
(7)
Europe
(7)
Western Pacific
(1)
Countries
Australia
(1)
Belgium
(2)
Canada
(3)
France
(2)
Luxembourg
(1)
Niger
(1)
Spain
(2)
United States of America
(4)
Diseases
COVID-19
(4)
Hepatitis A
(1)
Hepatitis B
(2)
Herpes zoster
(1)
Human papillomavirus (HPV)
(2)
Influenza
(5)
Japanese encephalitis
(2)
Malaria
(1)
Meningococcal disease
(1)
Mumps
(1)
Pertussis
(1)
Pneumococcal disease
(7)
Rabies
(1)
Publication date
2023
(2)
2022
(6)
2021
(3)
2020
(1)
2019
(1)
2018
(1)
2017
(1)
Target population
Adults
(8)
Newborn
(8)
Adolescents
(6)
All age groups
(1)
Children
(22)
Healthcare workers
(4)
Migrants
(1)
Older adults
(10)
Pregnant women
(8)
Risk group
(7)
Available to download in languages
English (EN)
(8)
French (FR)
(5)
Spanish (ES)
(2)
16 results found
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2023
∙
NACI
Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations
2022
Vaccination recommendations against flu in children aged 6 to 59 months
2022
∙
ACIP
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
Vaccination recommendations against flu in children aged 6 to 59 months
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against COVID-19 with mRNA vaccines for children from 6 months of age in Belgium
2022
Niger-NITAG advice on the introduction of the malaria vaccine in routine immunization
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
NACI
NACI rapid response: Recommended use of AstraZeneca COVID-19 vaccine in younger adults
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register